Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East

Mark Forums Read

General Cancer News Latest Breast Cancer News from Moreover Technologies

Prev

Previous Post

Next Post

Next

11-17-2013, 10:40 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,023	Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East Eisai announces today that Halaven (eribulin) will be marketed in selected countries within the Middle East region through a new partnership between Eisai EMEA (Europe, the Middle East, Africa, Russia and Oceania) and NewBridge Pharmaceuticals. More...

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Switch to Linear Mode Switch to Hybrid Mode Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 08:41 AM.

free webpage hit counter